Amgen Inc. Cedear (AMGN)
BCBA
Closed
Aug 21, 2026
Day's Range
23,010.0052 wk Range
12,320.00Overview - AMGN - Amgen Inc. Cedear
Key Statistics
Valuation
Enterprise Value
515,010.84T
P/E (Trailing)
‪0.19‬
PEG Ratio
‪0.0029‬
Price / Sales (TTM)
‪66.10‬
Price / Book
‪19.98‬
EV / EBITDA
‪19,926.77‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
541.00M
Float
14.97B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪19,613.80‬
200-Day Avg
‪17,774.55‬
Dividends
Payout Ratio
‪0.41%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMGN - Amgen Inc. Cedear
Peers - AMGN - Amgen Inc. Cedear
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AMGNBCBAAmgen Inc.2.52TMarket Cap+42.86%52-week change0.19P/E (Trailing)‪22.95%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change59.10P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR341.48TMarket Cap+44.54%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.31P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR101.00TMarket Cap+18.54%52-week change6.36P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.64TMarket Cap+33.95%52-week change7.75P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.72.55TMarket Cap+40.10%52-week change5.14P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - AMGN - Amgen Inc. Cedear
About
Amgen Inc. is a leading biotechnology company that specializes in the discovery, development, and commercialization of innovative human therapeutics. With its headquarters in Thousand Oaks, California, Amgen has a prominent role in the life sciences sector, focusing on advancing medicines for serious illnesses. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
